Research Chat

Raymond March, Ph.D.

Assistant Professor of Economics

Bio

Raymond March is a scholar at the Challey Institute for Global Innovation and Growth with the Center for the Study of Public Choice and Private Enterprise and an assistant professor of economics in the Department of Agribusiness and Applied Economics at North Dakota State University. He teaches courses in microeconomics, the history of economic thought, and health economics. His research examines the public and private provision and governance of health care in the United States, particularly in pharmaceutical markets. His research has appeared in Southern Economic JournalPublic ChoiceResearch PolicyJournal of Institutional Economics, and other academic publications. He co-edited the 2022 book Pandemics and Liberty. Dr. March is a research fellow at the Independent Institute and director of FDAReview.org, an educational research and communications project on the U.S. Food and Drug Administration (FDA). He regularly blogs on health policy at The Beacon and the American Institute for Economic Research.

Education
  • Ph.D., Agricultural and Applied Economics, Texas Tech University
  • M.A., Agricultural and Applied Economics, Texas Tech University
  • B.S., Economics and Business Management, Florida Gulf Coast University
Expertise
  • Health care economics
  • Regulations
  • Food and Drug Administration (FDA)
  • Pharmaceutical markets
  • Drug pricing
  • Rural health and telemedicine

 

Recent Media
Blog | Independent Institute | Did Healthcare Spending Really Return to Pre-Pandemic Levels?
Blog | Independent Institute | Another Infant Formula Shortage? Blame the FDA
Article | NPR | These Are Some Christmas Traditions Around the World, From Fistfights to KFC
Op-Ed | The Hill | Political Promises Won't End Drug Shortages
Blog | Independent Institute | Gene Therapy: A Promising Medical Frontier Hindered by Regulatory Roadblocks
Blog | Independent Institute | Who Should Decide if Weight-Loss Injections Should be Prescribed for Kids? 
Blog | Independent Institute | More Oversight Won't Help the US Baby Formula Market
Blog | Independent Institute | The FDA Should Stay Away from Laboratory Developed Tests
AIER | Psychedelics Will Help America's Mental Health Crisis - If the FDA Lets Them
DC Journal | Decongestant Drug Doesn't Work? Neither Does the FDA
MoneyGeek | Expert Advise on Best Health Insurance Option When Unemployed
Blog | Independent Institute | The Pandemic is Over, But Pandemic Policies Are Not
Blog | Catalyst | The Mental Health Crisis and FDA Hurdles
Blog | Independent Institute | FDA Efforts to Curb Youth Vaping Continue to Come Up Short
Blog | Independent Institute | The FDA Loosens Blood Donation Restrictions, Finally
Blog | Independent Institute | Recent Attacks on Recreational Marijuana Legalization Are All Smoke
WalletHub | Average Car Insurance Cost
MoneyGeek | Expert Advice on Most Affordable Health Insurance In North Dakota
MoneyGeek | Expert Advice: Health Insurance Costs
MoneyGeek | Expert Advice: Finding the Best Health Insurance
Blog | Independent Institute | FDA's Rare Positive Move
Blog | Independent Institute | Insulin Price-Caps: A Solution or a Recipe for Rationing?
Blog | Independent Institute | Are Insulin Prices About to Drop? The Devil is in the Details
Blog | Independent Institute | When is a Drug Safe and Effective Enough? 
Blog | Independent Institute | The FDA is Too Little Too Late in Tinkering with COVID-19 Booster Schedules
Blog | Independent Institute | Deregulation Remains Our Best Hope to Combat Alzheimer's Disease
Edited Volume | Pandemics and Liberty
Blog Contributor | Independent Institute
Blog Contributor | American Institute for Economic Research
AIER | Pandemics and Liberty: An Introduction
WebMD | Could Pot Prevent a Pot Belly? Researchers Get the Skinny on Cannabis
Stranded Technologies Podcast | The Case Against the FDA
Fortune | The FDA Could Easily Solve the Baby Formula Shortage by Allowing More Imports from Europe
The Forum of Fargo-Moorhead | Competition, Not More Regulation, is Needed to Lower Insulin Costs

 

 

 

Top of page